US Stock MarketDetailed Quotes

NHC National Healthcare

Watchlist
  • 91.460
  • -3.100-3.28%
Trading Mar 20 15:51 ET
1.41BMarket Cap14.01P/E (TTM)

National Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.52%107.3M
-50.30%12.79M
5.89%34.21M
28.84%50.66M
-30.39%9.65M
1,172.20%111.22M
115.63%25.73M
1,734.04%32.31M
49.84%39.32M
150.47%13.86M
Net income from continuing operations
56.36%102.09M
-78.44%6.03M
321.90%42.7M
70.30%27.11M
132.62%26.25M
226.82%65.29M
401.70%27.97M
425.75%10.12M
636.56%15.92M
-26.48%11.29M
Operating gains losses
64.29%-2.71M
87.79%-762K
156.64%81K
-288.16%-590K
-37.58%-1.44M
-992.58%-7.58M
-1,155.84%-6.24M
-139.94%-143K
-138.10%-152K
-109.02%-1.04M
Depreciation and amortization
-0.12%41.99M
-2.77%11.44M
4.78%10.62M
-7.39%9.34M
5.35%10.59M
3.82%42.03M
12.31%11.77M
-1.15%10.14M
0.82%10.08M
2.98%10.05M
Deferred tax
211.04%17.94M
-65.11%2.38M
521.90%9.52M
310.74%3.56M
650.45%2.48M
-3.79%5.77M
570.63%6.83M
-323.15%-2.26M
-36.60%866K
-87.27%331K
Change In working capital
-247.83%-25.72M
-907.45%-32.73M
-72.17%2.96M
16.67%18.69M
-143.21%-14.63M
123.60%17.4M
69.60%-3.25M
157.67%10.65M
108.05%16.02M
88.48%-6.02M
-Change in receivables
-208.93%-26.44M
-10.11%-6.54M
-1,318.91%-19.06M
768.57%16.28M
-443.81%-17.12M
-121.62%-8.56M
-504.48%-5.94M
-195.11%-1.34M
40.59%1.87M
44.03%-3.15M
-Change in inventory
-101.01%-599K
-9,107.69%-1.2M
58.73%-156K
367.35%131K
338.73%623K
-119.95%-298K
-106.19%-13K
-681.54%-378K
-104.01%-49K
3,650.00%142K
-Change in prepaid assets
1,039.16%6.28M
18.86%-2.53M
75.82%4.32M
167.82%1.34M
61.11%3.15M
93.98%-669K
-934.58%-3.11M
154.02%2.46M
22.78%-1.97M
144.63%1.96M
-Change in payables and accrued expense
-47.14%8.23M
-88.61%2.27M
26.49%5.4M
55.61%17.4M
14.86%-16.83M
138.28%15.57M
421.82%19.9M
124.35%4.27M
-12.54%11.18M
33.53%-19.77M
-Change in other current liabilities
-228.33%-13.55M
-97.01%-18.15M
208.01%11.5M
-323.43%-9.8M
-75.13%2.9M
218.16%10.56M
20.96%-9.21M
-64.36%3.74M
328.30%4.39M
299.40%11.65M
-Change in other working capital
-54.81%357K
-35.39%-6.59M
-50.13%950K
-1,219.53%-6.65M
300.54%12.65M
107.45%790K
-164.47%-4.87M
122.87%1.91M
118.76%594K
147.45%3.16M
Cash from discontinued investing activities
Operating cash flow
-3.52%107.3M
-50.30%12.79M
5.89%34.21M
28.84%50.66M
-30.39%9.65M
1,172.20%111.22M
115.63%25.73M
1,734.04%32.31M
49.84%39.32M
150.47%13.86M
Investing cash flow
Cash flow from continuing investing activities
-1,247.30%-236.69M
-19.23%-12.15M
-4,253.61%-223.56M
273.78%1.43M
-69.24%-2.42M
-193.88%-17.57M
-459.68%-10.19M
-693.66%-5.14M
63.44%-820K
75.90%-1.43M
Net PPE purchase and sale
1.08%-27.6M
5.17%-8.16M
13.13%-5.66M
-27.39%-7.83M
10.32%-5.96M
7.61%-27.9M
12.34%-8.6M
-11.20%-6.51M
-10.38%-6.15M
25.91%-6.64M
Net business purchase and sale
-2,998.72%-228.1M
-72.24%-8.03M
---217.31M
-24.74%-3.37M
--612K
---7.36M
---4.66M
--0
---2.7M
--0
Net investment purchase and sale
-5.49%16.91M
-39.19%1.87M
-161.88%-724K
52.38%12.85M
-44.12%2.91M
10.68%17.9M
-54.51%3.08M
-66.38%1.17M
172.15%8.43M
84.92%5.21M
Net other investing changes
1,140.30%2.09M
66,750.00%2.67M
-277.18%-365K
44.20%-226K
700.00%16K
-102.50%-201K
-100.07%-4K
-88.08%206K
-276.86%-405K
-99.11%2K
Cash from discontinued investing activities
Investing cash flow
-1,247.30%-236.69M
-14.32%-11.65M
-4,263.35%-224.06M
273.78%1.43M
-69.24%-2.42M
-193.88%-17.57M
-459.68%-10.19M
-693.66%-5.14M
63.44%-820K
75.90%-1.43M
Financing cash flow
Cash flow from continuing financing activities
335.85%100.34M
-96.22%-19.3M
1,518.74%139.32M
25.89%-7.61M
4.37%-12.07M
10.70%-42.55M
18.73%-9.83M
41.35%-9.82M
-23.06%-10.27M
-20.76%-12.62M
Net issuance payments of debt
2,830.99%136.14M
-684.93%-10M
11,803.82%147M
--0
29.39%-860K
-6.18%-4.99M
-6.17%-1.27M
-6.17%-1.26M
-6.18%-1.24M
-6.19%-1.22M
Net common stock issuance
135.32%766K
1,403.77%797K
-48.03%132K
21,983.33%1.33M
40.05%-1.49M
72.15%-2.17M
102.45%53K
103.85%254K
-99.46%6K
-1,600.00%-2.48M
Cash dividends paid
-3.95%-36.96M
-4.19%-9.42M
-4.08%-9.41M
-4.04%-9.09M
-3.46%-9.05M
-2.76%-35.56M
-3.03%-9.04M
-2.39%-9.04M
-2.63%-8.73M
-3.00%-8.75M
Net other financing activities
137.87%402K
-257.85%-674K
622.17%1.6M
148.05%148K
-290.64%-668K
130.51%169K
1,086.11%427K
266.17%221K
-248.79%-308K
74.25%-171K
Cash from discontinued financing activities
Financing cash flow
335.85%100.34M
-96.22%-19.3M
1,518.74%139.32M
25.89%-7.61M
4.37%-12.07M
10.70%-42.55M
18.73%-9.83M
41.35%-9.82M
-23.06%-10.27M
-20.76%-12.62M
Net cash flow
Beginning cash position
68.26%125.97M
-4.31%115.07M
60.93%165.61M
62.21%121.13M
68.26%125.97M
-37.48%74.87M
66.56%120.26M
12.38%102.91M
-1.63%74.68M
-37.48%74.87M
Current changes in cash
-156.84%-29.05M
-417.73%-18.15M
-391.24%-50.53M
57.54%44.47M
-2,458.73%-4.84M
213.87%51.1M
114.37%5.71M
189.58%17.35M
80.35%28.23M
99.57%-189K
End cash Position
-23.06%96.92M
-23.06%96.92M
-4.31%115.07M
60.93%165.61M
62.21%121.13M
68.26%125.97M
68.26%125.97M
66.56%120.26M
12.38%102.91M
-1.63%74.68M
Free cash flow
-4.34%79.7M
-72.96%4.63M
10.69%28.55M
29.11%42.83M
-48.86%3.69M
488.27%83.32M
172.07%17.13M
371.32%25.79M
82.55%33.17M
119.82%7.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.52%107.3M-50.30%12.79M5.89%34.21M28.84%50.66M-30.39%9.65M1,172.20%111.22M115.63%25.73M1,734.04%32.31M49.84%39.32M150.47%13.86M
Net income from continuing operations 56.36%102.09M-78.44%6.03M321.90%42.7M70.30%27.11M132.62%26.25M226.82%65.29M401.70%27.97M425.75%10.12M636.56%15.92M-26.48%11.29M
Operating gains losses 64.29%-2.71M87.79%-762K156.64%81K-288.16%-590K-37.58%-1.44M-992.58%-7.58M-1,155.84%-6.24M-139.94%-143K-138.10%-152K-109.02%-1.04M
Depreciation and amortization -0.12%41.99M-2.77%11.44M4.78%10.62M-7.39%9.34M5.35%10.59M3.82%42.03M12.31%11.77M-1.15%10.14M0.82%10.08M2.98%10.05M
Deferred tax 211.04%17.94M-65.11%2.38M521.90%9.52M310.74%3.56M650.45%2.48M-3.79%5.77M570.63%6.83M-323.15%-2.26M-36.60%866K-87.27%331K
Change In working capital -247.83%-25.72M-907.45%-32.73M-72.17%2.96M16.67%18.69M-143.21%-14.63M123.60%17.4M69.60%-3.25M157.67%10.65M108.05%16.02M88.48%-6.02M
-Change in receivables -208.93%-26.44M-10.11%-6.54M-1,318.91%-19.06M768.57%16.28M-443.81%-17.12M-121.62%-8.56M-504.48%-5.94M-195.11%-1.34M40.59%1.87M44.03%-3.15M
-Change in inventory -101.01%-599K-9,107.69%-1.2M58.73%-156K367.35%131K338.73%623K-119.95%-298K-106.19%-13K-681.54%-378K-104.01%-49K3,650.00%142K
-Change in prepaid assets 1,039.16%6.28M18.86%-2.53M75.82%4.32M167.82%1.34M61.11%3.15M93.98%-669K-934.58%-3.11M154.02%2.46M22.78%-1.97M144.63%1.96M
-Change in payables and accrued expense -47.14%8.23M-88.61%2.27M26.49%5.4M55.61%17.4M14.86%-16.83M138.28%15.57M421.82%19.9M124.35%4.27M-12.54%11.18M33.53%-19.77M
-Change in other current liabilities -228.33%-13.55M-97.01%-18.15M208.01%11.5M-323.43%-9.8M-75.13%2.9M218.16%10.56M20.96%-9.21M-64.36%3.74M328.30%4.39M299.40%11.65M
-Change in other working capital -54.81%357K-35.39%-6.59M-50.13%950K-1,219.53%-6.65M300.54%12.65M107.45%790K-164.47%-4.87M122.87%1.91M118.76%594K147.45%3.16M
Cash from discontinued investing activities
Operating cash flow -3.52%107.3M-50.30%12.79M5.89%34.21M28.84%50.66M-30.39%9.65M1,172.20%111.22M115.63%25.73M1,734.04%32.31M49.84%39.32M150.47%13.86M
Investing cash flow
Cash flow from continuing investing activities -1,247.30%-236.69M-19.23%-12.15M-4,253.61%-223.56M273.78%1.43M-69.24%-2.42M-193.88%-17.57M-459.68%-10.19M-693.66%-5.14M63.44%-820K75.90%-1.43M
Net PPE purchase and sale 1.08%-27.6M5.17%-8.16M13.13%-5.66M-27.39%-7.83M10.32%-5.96M7.61%-27.9M12.34%-8.6M-11.20%-6.51M-10.38%-6.15M25.91%-6.64M
Net business purchase and sale -2,998.72%-228.1M-72.24%-8.03M---217.31M-24.74%-3.37M--612K---7.36M---4.66M--0---2.7M--0
Net investment purchase and sale -5.49%16.91M-39.19%1.87M-161.88%-724K52.38%12.85M-44.12%2.91M10.68%17.9M-54.51%3.08M-66.38%1.17M172.15%8.43M84.92%5.21M
Net other investing changes 1,140.30%2.09M66,750.00%2.67M-277.18%-365K44.20%-226K700.00%16K-102.50%-201K-100.07%-4K-88.08%206K-276.86%-405K-99.11%2K
Cash from discontinued investing activities
Investing cash flow -1,247.30%-236.69M-14.32%-11.65M-4,263.35%-224.06M273.78%1.43M-69.24%-2.42M-193.88%-17.57M-459.68%-10.19M-693.66%-5.14M63.44%-820K75.90%-1.43M
Financing cash flow
Cash flow from continuing financing activities 335.85%100.34M-96.22%-19.3M1,518.74%139.32M25.89%-7.61M4.37%-12.07M10.70%-42.55M18.73%-9.83M41.35%-9.82M-23.06%-10.27M-20.76%-12.62M
Net issuance payments of debt 2,830.99%136.14M-684.93%-10M11,803.82%147M--029.39%-860K-6.18%-4.99M-6.17%-1.27M-6.17%-1.26M-6.18%-1.24M-6.19%-1.22M
Net common stock issuance 135.32%766K1,403.77%797K-48.03%132K21,983.33%1.33M40.05%-1.49M72.15%-2.17M102.45%53K103.85%254K-99.46%6K-1,600.00%-2.48M
Cash dividends paid -3.95%-36.96M-4.19%-9.42M-4.08%-9.41M-4.04%-9.09M-3.46%-9.05M-2.76%-35.56M-3.03%-9.04M-2.39%-9.04M-2.63%-8.73M-3.00%-8.75M
Net other financing activities 137.87%402K-257.85%-674K622.17%1.6M148.05%148K-290.64%-668K130.51%169K1,086.11%427K266.17%221K-248.79%-308K74.25%-171K
Cash from discontinued financing activities
Financing cash flow 335.85%100.34M-96.22%-19.3M1,518.74%139.32M25.89%-7.61M4.37%-12.07M10.70%-42.55M18.73%-9.83M41.35%-9.82M-23.06%-10.27M-20.76%-12.62M
Net cash flow
Beginning cash position 68.26%125.97M-4.31%115.07M60.93%165.61M62.21%121.13M68.26%125.97M-37.48%74.87M66.56%120.26M12.38%102.91M-1.63%74.68M-37.48%74.87M
Current changes in cash -156.84%-29.05M-417.73%-18.15M-391.24%-50.53M57.54%44.47M-2,458.73%-4.84M213.87%51.1M114.37%5.71M189.58%17.35M80.35%28.23M99.57%-189K
End cash Position -23.06%96.92M-23.06%96.92M-4.31%115.07M60.93%165.61M62.21%121.13M68.26%125.97M68.26%125.97M66.56%120.26M12.38%102.91M-1.63%74.68M
Free cash flow -4.34%79.7M-72.96%4.63M10.69%28.55M29.11%42.83M-48.86%3.69M488.27%83.32M172.07%17.13M371.32%25.79M82.55%33.17M119.82%7.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DexCom
DXCM
74.920
YETI Holdings
YETI
34.755
Dorian LPG
LPG
23.550
4
New Fortress Energy
NFE
10.405
5
Collegium Pharmaceutical
COLL
29.975
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings